300
Participants
Start Date
January 17, 2023
Primary Completion Date
March 30, 2027
Study Completion Date
March 31, 2027
Ferric derisomaltose
Participants assigned to the IV iron group will receive a single IV infusion of 1000 mg ferric derisomaltose (Monoferric, Pharmacosmos Therapeutics Inc., Morristown, NJ) in 250 mL given over 20 minutes.
Ferrous sulfate
325mg ferrous sulfate tablets (65 mg of elemental iron), 1 to 3 orally per day.
RECRUITING
GNP Research at Heme-on-Call, Miami
RECRUITING
University of Alabama Medical Center, Birmingham
RECRUITING
Michigan University Medical Center, Ann Arbor
RECRUITING
Washington University Medical Center, St Louis
RECRUITING
University of Utah Hospital, Salt Lake City
RECRUITING
Oregon Health and Sciences Uiversity Medical Center, Portland
RECRUITING
Hasbro Children's Hospital, Providence
RECRUITING
Women & Infants Hospital of Rhode Island, Providence
Hasbro Children's Hospital
OTHER
University of Michigan
OTHER
Washington University School of Medicine
OTHER
University of Utah
OTHER
University of Alabama at Birmingham
OTHER
Oregon Health and Science University
OTHER
GNP Research at Heme-on-Call
UNKNOWN
Women and Infants Hospital of Rhode Island
OTHER